Therapeutic factors secreted by mesenchymal stromal cells and tissue repair (Q37900258)

25 August 2017

1 reference

title

Therapeutic factors secreted by mesenchymal stromal cells and tissue repair (English)

1 reference

25 August 2017

Ryang Hwa Lee

1 reference

25 August 2017

Joo Youn Oh

series ordinal

1 reference

25 August 2017

Hosoon Choi

series ordinal

1 reference

25 August 2017

Nikolay Bazhanov

series ordinal

1 reference

25 August 2017

publication date

1 November 2011

1 reference

Journal of Cellular Biochemistry

25 August 2017

published in

1 reference

25 August 2017

volume

112

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

3073-3078

1 reference

Mesenchymal stem cell conditioned media attenuates in vitro and ex vivo myocardial reperfusion injury.

25 August 2017

cites work

1 reference

SDF-1α secreted by human CD133-derived multipotent stromal cells promotes neural progenitor cell survival through CXCR7

21 January 2018

1 reference

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties

21 January 2018

1 reference

IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis

21 January 2018

1 reference

Why are MSCs therapeutic? New data: new insight.

21 January 2018

1 reference

Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat.

21 January 2018

1 reference

Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages.

21 January 2018

1 reference

Intravenously administered BMSCs reduce neuronal apoptosis and promote neuronal proliferation through the release of VEGF after stroke in rats

21 January 2018

1 reference

Conditions controlling the proliferation of haemopoietic stem cells in vitro

21 January 2018

1 reference

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

21 January 2018

1 reference

Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression

21 January 2018

1 reference

Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment

21 January 2018

1 reference

HLA-G expression is up-regulated by progesterone in mesenchymal stem cells.

21 January 2018

1 reference

Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains

21 January 2018

1 reference

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung

21 January 2018

1 reference

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

21 January 2018

1 reference

Human bone marrow mesenchymal stem cells expressing SDF-1 promote hematopoietic stem cell function of human mobilised peripheral blood CD34+ cells in vivo and in vitro.

21 January 2018

1 reference

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

21 January 2018

1 reference

Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice

21 January 2018

1 reference

Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources

21 January 2018

1 reference

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma

21 January 2018

1 reference

Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury.

21 January 2018

1 reference

Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

21 January 2018

1 reference

Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate

21 January 2018

1 reference

Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms

21 January 2018

1 reference

Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs).

21 January 2018

1 reference

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner

21 January 2018

1 reference

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

21 January 2018

1 reference

Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment

21 January 2018

1 reference

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

Interactions between human mesenchymal stem cells and natural killer cells

21 January 2018

1 reference

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

21 January 2018

1 reference

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart

21 January 2018

1 reference

Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury

21 January 2018

1 reference

Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia

21 January 2018

1 reference

Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis

21 January 2018

1 reference

Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha

21 January 2018

1 reference

The effects of mesenchymal stem cells on c-kit up-regulation and cell-cycle re-entry of neonatal cardiomyocytes are mediated by activation of insulin-like growth factor 1 receptor

21 January 2018

1 reference

Insulin-Like Growth Factor-1 Sustains Stem Cell Mediated Renal Repair

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.23250

1 reference

25 August 2017

1 reference